PHASEIN - Board of Directors & Auditors

Board of Directors & Auditors

PHASEIN's Board of Directors consist of a group of people with extensive experience in health care, finance and management.

Jan Lundahl

Born 1954.

Chairman of the Board.
Chairman of the Board since 2010. Chairman of PEQ AB, Twilfit AB, ILT AB, Board member of Atos Medical AB, Airsonett AB.

 

Robert Zyzanski

Born 1952.

Founder and CEO.
Director of the Board of PHASEIN since 2002.
Founder and President & CEO of Artema Medical AB (1990 - 2000).

 

Anders Eckerbom

Born 1955.

Founder and Director of Research and Development.
Director of the Board of PHASEIN since 2002.
Founder and R&D Manager of Artema Medical AB (1990 - 2000).

 

Ola Romney

Born 1959.

Director of the Board of PHASEIN since 2002.
Senior Investment Manager of SEB Företagsinvest AB since 2001.
Executive positions with SEB, Citibank (1990 - 2000).

Other assignments: Director of Cresco TiSystems NV, LipoCore AB, Index Pharmaceuticals AB.

 


Hans Andreasson

Born 1955.

Director of the Board of PHASEIN since 2009. Investment Director at SLS Invest.

Other board positions include vice chairman of the board of Oncolog Medical AB, board member of AdvanDx Inc., Atlas Antibodies AB, Gyros AB and Medical Vision AB.

 

Alan Raffensperger

Born 1960

Deputy Director of the Board since 2011. COO of Swedish Orphan Biovitrum AB.

CEO of Benechill, USA, 2011. Executive positions with Amgen, Roche Pharmaceuticals, Pharmacia 2010-1999.

 

 


Ulf Lewander

Born 1966.

Deputy Director of the Board of PHASEIN since 2003. Investment Manager of SEB Företagsinvest since 1999. Account Manager of SEB Corporate Clients (1996 – 1999)

Other assignments: Director of Prodacapo AB.

 

Auditors

KPMG Bohlins AB, Anders Linér, Authorized Public Accountant

PHASEIN AB, Svärdvägen 15, 182 33 Danderyd, Sweden, Phone: +46 8 544 98 150, Fax: +46 8 544 98 169
EPiTrace logger